NPHC
vs
S&P 500
NPHC
S&P 500
Over the past 12 months, NPHC has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +27% growth.
Stocks Performance
NPHC vs S&P 500
Performance Gap
NPHC vs S&P 500
Performance By Year
NPHC vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Nutra Pharma Corp
Glance View
Nutra Pharma Corp. operates as a bio pharmaceutical company. The company is headquartered in Coral Springs, Florida. The company went IPO on 2001-10-09. The firm conducts drug discovery research and development activities on its own and through its subsidiary, ReceptoPharm, Inc. Its first consumer product, Cobroxin, is an over-the-counter pain reliever designed to treat moderate to severe chronic pain. Its second consumer product, Nyloxin, an over-the-counter pain reliever that is a stronger version of Cobroxin and is designed to treat severe chronic pain. Its Pet Pain-Away is an over-the-counter pain reliever designed to treat pain in cats and dogs. Its Equine Pain-Away is an over-the-counter topical pain reliever designed to treat pain in horses. Its Luxury Feet is an over-the-counter pain reliever and anti-inflammatory product, which is designed for women who experience pain or discomfort due to high heels and stilettos. The company also manufactures a zeolite detoxifier, Cell Defender for a third-party distributor.
